Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22334443 | 0.90 | HTT (0.32) | — | |
| SCHEMBL22666397 | 0.85 | NPSR1 (0.37) | ALDH1A1MAPT | |
| SCHEMBL22319219 | 0.79 | TET2 (0.35) | TET2ALDH1A1MAPT | |
| SCHEMBL22319220 | 0.79 | TET2 (0.35) | TET2ALDH1A1MAPT | |
| SCHEMBL26969343 | 0.78 | HTT (0.32) | — | |
| SCHEMBL22883338 | 0.78 | — | — | |
| SCHEMBL22319216 | 0.76 | TET2 (0.33) | TET2ALDH1A1MAPT | |
| SCHEMBL22319215 | 0.76 | TET2 (0.33) | TET2ALDH1A1MAPT | |
| SCHEMBL609707 | 0.76 | HTT (0.31) | — | |
| SCHEMBL22666401 | 0.74 | TET2 (0.35) | TET2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200365945-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2020-11-19 | — | — | US | disclosed |
| EP-3694041-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | Daikin Industries, Ltd. (JP) | 2020-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200365945-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | RER1, CLIC1, PEF1 | TET2 611/4885ALDH1A1 2101/4885MAPT 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.